Literature DB >> 353

Local control of pulmonary resistance and lung compliance in the canine lung.

R L Coon, C C Rattenborg, J P Kampine.   

Abstract

Local control of pulmonary resistance and lung compliance was studied in the in situ left lower lobe of the canine lung. Recirculation of blood through the lobe while the Pco2 of the ventilatory gas was varied resulted in an increase in resistance and a decrease in compliance only when the pulmonary venous pH was greater than 7.42. Alternating sodium bicarbonate and lactic acid infusion while alveolar Pco2 was maintained below 5 mmHg demonstrated the dependence of the hypocapnic response on the acid-base status of the blood perfusing the respiratory airways. The increase in resistance and decrease in compliance observed at a pulmonary venous pH of 7.64 was comparable to that observed after lobar pulmonary artery occlusion. Varying degrees of hypoxia did not significantly affect bronchomotor tone, nor was the bronchoconstriction following lobar pulmonary artery occlusion affected by the hypoxia. Vagal stimulation superimposed on a stepwise increase in pulmonary venous pH from 7.32 to 7.62 resulted in an increase in resistance which paralleled the increase in resistance when pulmonary venous pH alone was increased. Compliance was not significantly affected by vagal stimulation at any level of pulmonary venous pH.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 353     DOI: 10.1152/jappl.1975.39.4.580

Source DB:  PubMed          Journal:  J Appl Physiol        ISSN: 0021-8987            Impact factor:   3.531


  13 in total

1.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

Review 2.  New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.

Authors:  Jossy van den Boogaard; Gibson S Kibiki; Elton R Kisanga; Martin J Boeree; Rob E Aarnoutse
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

Review 3.  Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.

Authors:  Robert S Wallis; Madhukar Pai; Dick Menzies; T Mark Doherty; Gerhard Walzl; Mark D Perkins; Alimuddin Zumla
Journal:  Lancet       Date:  2010-05-18       Impact factor: 79.321

4.  Microscopic-observation drug-susceptibility assay for the diagnosis of TB.

Authors:  David A J Moore; Carlton A W Evans; Robert H Gilman; Luz Caviedes; Jorge Coronel; Aldo Vivar; Eduardo Sanchez; Yvette Piñedo; Juan Carlos Saravia; Cayo Salazar; Richard Oberhelman; Maria-Graciela Hollm-Delgado; Doris LaChira; A Roderick Escombe; Jon S Friedland
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

5.  Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru.

Authors:  L Caviedes; T S Lee; R H Gilman; P Sheen; E Spellman; E H Lee; D E Berg; S Montenegro-James
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

7.  Matrix metalloproteinase-1 is regulated in tuberculosis by a p38 MAPK-dependent, p-aminosalicylic acid-sensitive signaling cascade.

Authors:  Lucinda Rand; Justin A Green; Luísa Saraiva; Jon S Friedland; Paul T G Elkington
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

8.  Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.

Authors:  Rany Condos; Nicos Hadgiangelis; Eric Leibert; Germaine Jacquette; Timothy Harkin; William N Rom
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

9.  Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

Authors:  Marcus B Conde; Anne Efron; Carla Loredo; Gilvan R Muzy De Souza; Nadja P Graça; Michelle C Cezar; Malathi Ram; Mohammad A Chaudhary; William R Bishai; Afranio L Kritski; Richard E Chaisson
Journal:  Lancet       Date:  2009-04-04       Impact factor: 79.321

10.  Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum.

Authors:  Dan Agranoff; Delmiro Fernandez-Reyes; Marios C Papadopoulos; Sergio A Rojas; Mark Herbster; Alison Loosemore; Edward Tarelli; Jo Sheldon; Achim Schwenk; Richard Pollok; Charlotte F J Rayner; Sanjeev Krishna
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

View more
  1 in total

1.  Changes in respiratory system resistance and reactance following acute respiratory and metabolic alkalosis in dogs.

Authors:  Isuta Nishio
Journal:  J Anesth       Date:  1996-12       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.